The research group in Virology and HIV/AIDS maintains an activity in clinical and experimental research in diagnosis, pathogenesis and treatment in human virology, including HIV infection, through a platform for conducting clinical trials and a laboratory infrastructure that allows the study of complex aspects to be addressed with advanced techniques of molecular, cellular and genomic virology.
The objectives of the research group are the following:
- Study of new antiviral strategies for the treatment of patients infected with HIV, with and without HCV co-infection, and Herpes Virus associated with immunosuppression.
- Study of the development and detection of antiviral resistance in the immunosuppressed patient.
- Characterization of the latent viral reservoir in HIV-infected patients under viral suppresive treatment.
- Immunological and kinetic response of neutralizing antibody production in convalescent patients of Ebola virus infection.
- Characterization of the pathogenic potential of variants of Cytomegalovirus (CMV) in congenital infection.